Ponatinib Hydrochloride
In Stock•Starting at $23 for 100 mg•Purity ≥ 99%
| CAS No. | 1114544-31-8 |
|---|---|
| MDL No. | MFCD28656903 |
| MF | C29H28ClF3N6O |
| MW | 569.00 |
| InChI Key | BWTNNZPNKQIADY-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 99% | $23 | In Stock | |
| 250 mg | 99% | $36 | In Stock | |
| 1 g | 99% | $98 | In Stock | |
| 5 g | 99% | $310 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Ponatinib hydrochloride is the hydrochloride salt of ponatinib. It is a potent pan-tyrosine kinase inhibitor active against all single resistance ABL kinase mutations, including T315I. It is approved for the treatment of chronic myeloid leukemia. It functions as an antineoplastic agent and tyrosine kinase inhibitor, containing ponatinib(1+).
| CAS No. | 1114544-31-8 |
|---|---|
| Product Name | Ponatinib Hydrochloride |
Biological Targets
ABL1·BCR
Associated Conditions
acute myeloid leukemia·myeloid leukemia·Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive·lymphoid leukemia·acute lymphoblastic leukemia·
* The information provided here is compiled from public sources and is for reference only.
